Overview

A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.

Status:
Completed
Trial end date:
2016-07-15
Target enrollment:
Participant gender:
Summary
A Phase IV, Randomised, Double-blind, Single-centre clinical trial in healthy male and female participants aged 18 to 55, that was designed to assess and compare the pain intensity at an injection site as well as the duration of pain following a single dose subcutaneous administration of two low molecular weight heparins (LMWH) respectively.
Phase:
Phase 4
Details
Lead Sponsor:
Aspen Global Incorporated
Treatments:
Heparin